Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy

Grazyna Adamus, Landon Karren

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Autoantibodies against various retinal proteins, including anti-carbonic anhydrase II (CAII) autoantibodies, have been found in patients with cancer-associated retinopathy and autoimmune retinopathy without diagnosed cancer. We studied sera from retinopathy patients that showed reactivity with a 30-kDa retinal protein, which was identified as carbonic anhydrase II (CAII), and immunolabeled cells in human retina. The goal of the study was to examine whether patients' autoantibodies induce pathogenic effects on the catalytic function of CAII, which may have metabolic consequences on cell survival. Our findings revealed that anti-CAII autoantibodies have the capacity to induce cellular damage by impairing CAII cellular function through inhibiting the catalytic activity of CAII in a dose dependent manner, decreasing intracellular pH, increasing intracellular calcium, which in effect decreases retinal cell viability. The destabilized catalytic function of CAII and alterations in cytosolic pH were found very early, suggesting that autoantibodies are the inducers of apoptosis. In summary, our study showed that anti-CAII autoantibodies provoke pathogenic effects on retinal cells by decreasing cell survival by blocking the CAII cellular functions. The current experiments may facilitate better understanding the role of the immune system in retinal degeneration and help to develop better strategies for therapy of autoimmune retinopathy.

Original languageEnglish (US)
Pages (from-to)133-139
Number of pages7
JournalJournal of Autoimmunity
Volume32
Issue number2
DOIs
StatePublished - Mar 2009

Fingerprint

Carbonic Anhydrase II
Autoimmunity
Autoantibodies
Cell Survival
Ocular Paraneoplastic Syndromes
Retinal Degeneration
Retina
Immune System
Proteins
Apoptosis
Calcium

Keywords

  • Autoantibody
  • Autoimmune retinopathy
  • Calcium
  • Carbonic anhydrase II
  • pH
  • Retina

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. / Adamus, Grazyna; Karren, Landon.

In: Journal of Autoimmunity, Vol. 32, No. 2, 03.2009, p. 133-139.

Research output: Contribution to journalArticle

@article{975f937caae542f5b9023132f8f56630,
title = "Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy",
abstract = "Autoantibodies against various retinal proteins, including anti-carbonic anhydrase II (CAII) autoantibodies, have been found in patients with cancer-associated retinopathy and autoimmune retinopathy without diagnosed cancer. We studied sera from retinopathy patients that showed reactivity with a 30-kDa retinal protein, which was identified as carbonic anhydrase II (CAII), and immunolabeled cells in human retina. The goal of the study was to examine whether patients' autoantibodies induce pathogenic effects on the catalytic function of CAII, which may have metabolic consequences on cell survival. Our findings revealed that anti-CAII autoantibodies have the capacity to induce cellular damage by impairing CAII cellular function through inhibiting the catalytic activity of CAII in a dose dependent manner, decreasing intracellular pH, increasing intracellular calcium, which in effect decreases retinal cell viability. The destabilized catalytic function of CAII and alterations in cytosolic pH were found very early, suggesting that autoantibodies are the inducers of apoptosis. In summary, our study showed that anti-CAII autoantibodies provoke pathogenic effects on retinal cells by decreasing cell survival by blocking the CAII cellular functions. The current experiments may facilitate better understanding the role of the immune system in retinal degeneration and help to develop better strategies for therapy of autoimmune retinopathy.",
keywords = "Autoantibody, Autoimmune retinopathy, Calcium, Carbonic anhydrase II, pH, Retina",
author = "Grazyna Adamus and Landon Karren",
year = "2009",
month = "3",
doi = "10.1016/j.jaut.2009.02.001",
language = "English (US)",
volume = "32",
pages = "133--139",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy

AU - Adamus, Grazyna

AU - Karren, Landon

PY - 2009/3

Y1 - 2009/3

N2 - Autoantibodies against various retinal proteins, including anti-carbonic anhydrase II (CAII) autoantibodies, have been found in patients with cancer-associated retinopathy and autoimmune retinopathy without diagnosed cancer. We studied sera from retinopathy patients that showed reactivity with a 30-kDa retinal protein, which was identified as carbonic anhydrase II (CAII), and immunolabeled cells in human retina. The goal of the study was to examine whether patients' autoantibodies induce pathogenic effects on the catalytic function of CAII, which may have metabolic consequences on cell survival. Our findings revealed that anti-CAII autoantibodies have the capacity to induce cellular damage by impairing CAII cellular function through inhibiting the catalytic activity of CAII in a dose dependent manner, decreasing intracellular pH, increasing intracellular calcium, which in effect decreases retinal cell viability. The destabilized catalytic function of CAII and alterations in cytosolic pH were found very early, suggesting that autoantibodies are the inducers of apoptosis. In summary, our study showed that anti-CAII autoantibodies provoke pathogenic effects on retinal cells by decreasing cell survival by blocking the CAII cellular functions. The current experiments may facilitate better understanding the role of the immune system in retinal degeneration and help to develop better strategies for therapy of autoimmune retinopathy.

AB - Autoantibodies against various retinal proteins, including anti-carbonic anhydrase II (CAII) autoantibodies, have been found in patients with cancer-associated retinopathy and autoimmune retinopathy without diagnosed cancer. We studied sera from retinopathy patients that showed reactivity with a 30-kDa retinal protein, which was identified as carbonic anhydrase II (CAII), and immunolabeled cells in human retina. The goal of the study was to examine whether patients' autoantibodies induce pathogenic effects on the catalytic function of CAII, which may have metabolic consequences on cell survival. Our findings revealed that anti-CAII autoantibodies have the capacity to induce cellular damage by impairing CAII cellular function through inhibiting the catalytic activity of CAII in a dose dependent manner, decreasing intracellular pH, increasing intracellular calcium, which in effect decreases retinal cell viability. The destabilized catalytic function of CAII and alterations in cytosolic pH were found very early, suggesting that autoantibodies are the inducers of apoptosis. In summary, our study showed that anti-CAII autoantibodies provoke pathogenic effects on retinal cells by decreasing cell survival by blocking the CAII cellular functions. The current experiments may facilitate better understanding the role of the immune system in retinal degeneration and help to develop better strategies for therapy of autoimmune retinopathy.

KW - Autoantibody

KW - Autoimmune retinopathy

KW - Calcium

KW - Carbonic anhydrase II

KW - pH

KW - Retina

UR - http://www.scopus.com/inward/record.url?scp=62149107035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62149107035&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2009.02.001

DO - 10.1016/j.jaut.2009.02.001

M3 - Article

VL - 32

SP - 133

EP - 139

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 2

ER -